[1]
“The effect of SpeechVive device on speech intelligibility in Parkinson’s Disease patients: Randomized Clinical Trial Protocol ”, PPCR, vol. 8, no. 2, pp. 9–16, Jul. 2022, doi: 10.21801/ppcrj.2022.82.2.